Skip to main content
SpringerLink
Log in

The National Health Service Pharmaceuticals Market

Recent and Prospective Reforms

  • Short Communication
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Office of Health Economics. Compendium of Health Statistics, 8th ed., Box 4.17, p. 49, 1992

    Google Scholar 

  2. Griffin TD. An economist’s view of patient co-payment for prescribed medicines in the European community. Int Pharm J 1992; 6 (1): 15–8

    Google Scholar 

  3. Burstall ML. Indicative drug budgets for general practitioners: some doubts. In Green DG, editor. The NHS reforms: whatever happened to consumer choice? London: IEA, 1990: pp. 47–73

    Google Scholar 

  4. IMS International. Griffin JP. Is therapeutic conservatism cost effective? Presentation to EFPIA General Assembly, Salzburg, p. 1, 1993

    Google Scholar 

  5. European Transplant and Dialysis Association. Combined report on regular dialysis and transplantation in Europe, XXI, 1990 in Nephrol Dial Trans 1991; 6 (Suppl. 4): 5–29. Quoted in Griffin J.P., ‘Is therapeutic conservatism cost effective?’, Presentation to EFPIA General Assembly, Salzburg, May 1993, p. 6

    Google Scholar 

  6. Lonsdale J. Treatment by budget. A study of 5HT3 prescribing in the UK and Europe, Isis Research Ltd, BPMRG Meeting, Brighton, April 1993. Quoted in Griffin J.P., ‘Is therapeutic conservatism cost effective?’, Presentation to EFPIA General Assembly, Salzburg, May 1993, p. 6

    Google Scholar 

  7. Parliamentary Office of Science and Technology. Technology and the NHS Drugs Bill. Technical Report, April 1993

    Google Scholar 

  8. Department of Health. The patient’s charter. London, HMSO, 1991, p. 9

    Google Scholar 

  9. Office of Health Economics. Compendium of Health Statistics 1992, Table 4.26, p. 64

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IEA Health and Welfare Unit, Institute of Economic Affairs, 2 Lord North St, Westminster, London, SW1P3LB, England

    David G. Green (Director)

Authors
  1. David G. Green
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Green, D.G. The National Health Service Pharmaceuticals Market. Pharmacoeconomics 6 (Suppl 1), 11–14 (1994). https://doi.org/10.2165/00019053-199400061-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199400061-00006

Keywords

Search

Navigation